Minute Insight: Medtronic Counters Abbott With New Micra Leadless Pacemakers
Executive Summary
About a month after it approved Abbott’s Aveir VR leadless pacemaker, the FDA approved two new models of Medtronic’s Micra leadless pacemaker.
You may also be interested in...
News We’re Watching: GE And Google Announce AI Initiatives, Medtronic Announces Approvals, And More
Medtech Insight's News We're Watching highlights medtech industry developments that you may have missed over the last few weeks. UK-based CMR Surgical announced more milestones, Newfoundlound Diagnostics introduced a new UTI diagnostic, Google announced a new health care-oriented large language model, and more.
Cardio Catch-Up: Abbott Plans To Expand Pacemaker Market With Leadless Aveir DR
The FDA approved Abbott’s Aveir DR dual-chamber leadless pacemaker system, which will complement Abbott’s Aveir VR technology and help Abbott compete directly with Medtronic in the growing leadless cardiac rhythm management device market.
Long-Term Data Affirm Durability Of Medtronic’s EV-ICD
Medtech Insight’s Cardiovascular Catch-Up highlights recent news on cardiovascular tech innovations that you may have missed. This edition is an update on Medtronic's Extravascular ICD (EV-ICD).